Rheumatoid arthritis /
Saved in:
| Edition: | 2nd ed. |
|---|---|
| Imprint: | Oxford ; New York : Oxford University Press, 2006. |
| Description: | xvii, 575 p. : ill. (some col.) ; 29 cm. |
| Language: | English |
| Subject: | |
| Format: | E-Resource Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/6205692 |
Table of Contents:
- Preface
- Section 1. Etiology
- 1. Genetics of rheumatoid arthritis
- 2. Epidemiology and determinants of susceptibility
- 3. Microbes in the pathogenesis of rheumatoid arthritis
- 4. Experimental models for rheumatoid arthritis
- Section 2. Mechanisms of inflammation
- 5. The role of macrophages in rheumatoid arthitis
- 6. The role of T lymphocytes in rheumatoid arthritis
- 7. The role of neutrophils in the pathogenesis of rheumatoid arthritis
- 8. The role of fibroblast-like synoviocytes in rheumatoid arthritis
- 9. The roles of B cells in rheumatoid arthritis
- 10. Innate immunity and immune complexes in rheumatoid arthritis
- 11. Angiogenesis and cell trafficking
- 12. Cytokine networks
- 13. Autoantibodies in rheumatoid arthritis
- 14. Mechanisms of fibroblast-mediated joint destruction
- 15. Pain mechanisms in rheumatoid arthritis
- 16. The stress system and the hypothalamic-pituitary adrenal (HPA) axis in rheumatoid arthritis
- Section 3. Clinical Aspects
- 17. Examination of the synovium and synovial fluid
- 18. Clinical aspects of rheumatoid arthritis
- 19. Imaging in rheumatoid arthritis
- 20. Susceptibility, prognosis & mortality
- 21. Biomarkers for cartilage and bone in rheumatoid arthritis
- Section 4. Drug Therapy
- 22. NSAIDS and analgesics, Garry Graham, Richard O'Day
- 23. Systemic and intra-articular glucorticoids in rheumatoid arthritis
- 24. Methotrexate and Leflunomide
- 25. Gold, antimalarials, sulfasalazine, and other DMARDS
- 26. Combination therapy with synthetic DMARDs in the treatment of rheumatoid arthritis
- 27. Biologics in the treatment of rheumatoid arthritis
- Section 5. Non-Drug Therapy
- 28. The impact of physiotherapy
- 29. Patient Education
- 30. Occupation therapy and assistive products and technology
- 31. Psychological and social aspects
- 32. Pain management
- 33. Health econoics
- Section 6. Surgical Therapy
- 34. Large joints and feet
- 35. The hand
- 36. The cervical spine, ATH Casey & Alan Crockard
- Section 7. Frontiers of Therapy
- 37. Design of trials involving clinical endpoints
- 38. Clinical trials with imaging and biomark endpoints
- 39. New biologics: cytokines
- 40. New biologics: T and B cell modulators
- 41. Inhibibition of proteolytic activity involved in cartilage breakdown
- 42. Signal transduction in rheumatic diseases
- 43. Mesenchymal stem cells in arthritis
